Anika Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $365.6M
Liabilities Breakdown FY2020
Total Liabilities: $93.2M
Asset Breakdown
Total Assets: $365.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $95.8M | 26.2% |
| Accounts Receivable | $24.1M | 6.6% |
| Inventory | $46.2M | 12.6% |
| Property, Plant & Equipment | $50.6M | 13.8% |
| Goodwill | $8.4M | 2.3% |
| Intangible Assets | $91.2M | 24.9% |
| Other Assets | $49.3M | 13.5% |
Liabilities Breakdown
Total Liabilities: $93.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.0M | 9.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $84.2M | 90.4% |